184 results
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
by not less than a majority of the Board at a meeting of the Board called and held for such purpose. For purposes of this Agreement, “Cause” shall mean … , to constitute at least a majority of the Board, provided that any person becoming a director of the Company subsequent to the Commencement Date shall
SD
EX-1.01
HBIO
Harvard Bioscience Inc.
30 May 23
Conflict minerals disclosure
4:17pm
; and (iii) 25 were identified as non-conformant under the RMAP.
As noted above, we submitted CMRTs to our Tier 1 suppliers. The majority
SD
EX-1.01
jvf f2qbqx9vir
20 May 22
Conflict minerals disclosure
4:15pm
8-K
EX-10.1
nkl1 ihvjlwgk86c3q
17 May 22
Departure of Directors or Certain Officers
4:39pm
SD
EX-1.01
6ky518z
27 May 21
Conflict minerals disclosure
4:26pm
8-K
EX-10.1
o6wz3hm
19 May 21
Departure of Directors or Certain Officers
4:20pm
8-K
EX-10.1
d9w cavp0s
23 Dec 20
Harvard Bioscience Announces New Credit Facility
5:15pm
S-8
EX-4.8
v822qk8oq
6 Nov 20
Registration of securities for employees
5:00pm